Sonothera Therapeutics

SonoThera™

This company develops an ultrasound-guided non-viral platform to deliver genetic medicines for patients with chronic and rare diseases.

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.

Gene Therapy Delivery Methods

This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.

Anjarium BioSciences

This company develops non-viral gene therapies and synthetic DNA vectors for patients with genetic diseases and life sciences researchers.

Exact Therapeutics

The company develops an ultrasound-mediated platform for delivering targeted therapies to patients with cancer, neurological conditions and infectious diseases.

Aera Therapeutics

This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.

Borea Therapeutics

The company develops bio-conjugated viral vectors for gene therapy to treat patients with genetic or chronic diseases.

Immitra Bio

This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.